Peter Loftus on Muck Rack

Peter Loftus Verified

Wall Street Journal @WSJ reporter covering pharmaceutical industry. Contact me at 215-881-7127, peter.loftus@wsj.com.

Sep 15, 2014

Gilead to allow cheaper hepatitis C drug in developing countries. on.wsj.com/1wvBI2P via @WSJ

Sep 10, 2014

RT @stefaniei: The cost of employer-provided health coverage continued its muted growth this year -- 3% increase. on.wsj.com/1lVGcft @annawmathews

Sep 10, 2014

'But these go to ten-one'...What's the best language for learning math? Hint: You're not reading it on.wsj.com/1uv2TYi via @WSJ

Sep 05, 2014

RT @JeanneWhalen: The "very naughty" habit of the British gardener: throwing pesky snails into the neighbor's yard. on.wsj.com/1qAY0eA via @WSJ

Sep 05, 2014

RT @pharmalot: Lilly backs lawsuit against CMS over the rejection of its Alzheimer's diagnostic agent blogs.wsj.com/pharmalot/2014… #pharma $LLY #Alzheimer's #CMS

Sep 04, 2014

RT @adamfeuerstein: Per an earlier @MarkSchoenebaum email, he pegged buyside consensus for PD-1 price at $150K/year. $MRK $BMY

Sep 04, 2014

US Cost of Merck's Melanoma Drug: $12,500 Per Patient Per Month, Or $150K for Year's Worth Of Treatment $MRK

Sep 04, 2014

RT @ronwinslow: FDA approves a new kind of cancer drug from Merck that bolsters the body's immune system on.wsj.com/1qAkBYy via @WSJ via @loftus

Sep 04, 2014

FDA approves Merck's anti-PD-1 'Keytruda' treatment for melanoma. $MRK



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Peter Loftus, email loftus@muckrack.com.


Share This Profile